Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses.
Adibfar S, Masjedi A, Nazer A, Rashidi B, Karpisheh V, Izadi S, Hassannia H, Gholizadeh Navashenaq J, Mohammadi H, Hojjat-Farsangi M, Tarokhian H, Jadidi-Niaragh F. Adibfar S, et al. Among authors: rashidi b. Life Sci. 2022 Nov 15;309:121008. doi: 10.1016/j.lfs.2022.121008. Epub 2022 Sep 27. Life Sci. 2022. PMID: 36179812
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells.
Fathi M, Bahmanpour S, Barshidi A, Rasouli H, Karoon Kiani F, Mahmoud Salehi Khesht A, Izadi S, Rashidi B, Kermanpour S, Mokhtarian R, Karpisheh V, Hassannia H, Mohammadi H, Jalili A, Jadidi-Niaragh F. Fathi M, et al. Among authors: rashidi b. Int Immunopharmacol. 2021 Dec;101(Pt A):108288. doi: 10.1016/j.intimp.2021.108288. Epub 2021 Oct 29. Int Immunopharmacol. 2021. PMID: 34710844
Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Kheshti AMS, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, Noukabadi FK, Kiani FK, Hassannia H, Atyabi F, Kiaie SH, Kashanchi F, Navashenaq JG, Mohammadi H, Bagherifar R, Jafari R, Zolbanin NM, Jadidi-Niaragh F. Kheshti AMS, et al. Among authors: rashidi b. Pharm Res. 2022 Feb;39(2):353-367. doi: 10.1007/s11095-022-03169-2. Epub 2022 Feb 15. Pharm Res. 2022. Retraction in: Pharm Res. 2023 Feb;40(2):615-616. doi: 10.1007/s11095-022-03456-y PMID: 35166995 Retracted.
Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Salehi AM, Kheshti, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, Noukabadi FK, Kiani FK, Hassannia H, Atyabi F, Kiaie SH, Kashanchi F, Navashenaq JG, Mohammadi H, Bagherifar R, Jafari R, Zolbanin NM, Jadidi-Niaragh F. Salehi AM, et al. Among authors: rashidi b. Pharm Res. 2023 Feb;40(2):615-616. doi: 10.1007/s11095-022-03456-y. Pharm Res. 2023. PMID: 36477758 No abstract available.
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.
Khodakarami A, Kashani MA, Nazer A, Kheshti AM, Rashidi B, Karpisheh V, Masjedi A, Abolhasani S, Izadi S, Bagherifar R, Hejazian SS, Mohammadi H, Movassaghpour A, Feizi AAH, Hojjat-Farsangi M, Jadidi-Niaragh F. Khodakarami A, et al. Among authors: rashidi b. Cell Commun Signal. 2023 Aug 1;21(1):188. doi: 10.1186/s12964-023-01213-1. Cell Commun Signal. 2023. PMID: 37528446 Free PMC article.
Corrigendum to "Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells" [Int. Immunopharmacol. 101 (2021) 108288].
Fathi M, Bahmanpour S, Barshidi A, Rasouli H, Kiani FK, Khesht AMS, Izadi S, Rashidi B, Kermanpour S, Mokhtarian R, Karpisheh V, Hassannia H, Mohammadi H, Jalili A, Jadidi-Niaragh F. Fathi M, et al. Among authors: rashidi b. Int Immunopharmacol. 2024 Dec 5;142(Pt A):113118. doi: 10.1016/j.intimp.2024.113118. Epub 2024 Sep 12. Int Immunopharmacol. 2024. PMID: 39271379 No abstract available.
MicroRNAs, endometrial receptivity and molecular pathways.
Salmasi S, Heidar MS, Khaksary Mahabady M, Rashidi B, Mirzaei H. Salmasi S, et al. Among authors: rashidi b. Reprod Biol Endocrinol. 2024 Nov 11;22(1):139. doi: 10.1186/s12958-024-01304-9. Reprod Biol Endocrinol. 2024. PMID: 39529197 Free PMC article. Review.
142 results